世界の止血剤&組織シーラント市場2020-2024

【英語タイトル】Global Hemostats and Tissue Sealants Market 2020-2024

Technavioが出版した調査資料(IRTNTR40802 )・商品コード:IRTNTR40802
・発行会社(調査会社):Technavio
・発行日:2020年1月2日
・ページ数:120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:アジア、ヨーロッパ、北米、その他の地域
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥320,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥384,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥512,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは止血剤&組織シーラントの世界市場について調査・分析し、エグゼクティブサマリー、レポート範囲、市場環境、市場規模、ファイブフォース分析、製品別(止血剤、組織シーラント&接着剤、フィブリンシーラント)分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因・課題、市場トレンド、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリ
・レポート範囲
・市場環境
・市場規模
・ファイブフォース分析
・止血剤&組織シーラントの世界市場:製品別(止血剤、組織シーラント&接着剤、フィブリンシーラント)
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因・課題
・市場トレンド
・企業状況
・企業分析
【レポートの概要】

Global Hemostats And Tissue Sealants Market 2020-2024
Technavio has been monitoring the global hemostats and tissue sealants market and it is poised to grow by USD 921.95 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our reports on global hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by use of hemostats and tissue sealants in surgeries.In addition, increasing r&d on novel hemostats and tissue sealants is anticipated to boost the growth of the global hemostats and tissue sealants market as well.

Market Segmentation
Technavio’s global hemostats and tissue sealants market is segmented as below:
Product:
• Hemostats
• Tissue Sealants And Adhesives
• Fibrin Sealants

Geographic Segmentation:
• Asia
• Europe
• North America
• ROW

Key Trends for global hemostats and tissue sealants market growth
This study identifies increasing r&d on novel hemostats and tissue sealants as the prime reasons driving the global hemostats and tissue sealants market growth during the next few years.

Prominent vendors in global hemostats and tissue sealants market
We provide a detailed analysis of around 25 vendors operating in the global hemostats and tissue sealants market , including some of the vendors such as Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Holdings Corp., Johnson & Johnson Services Inc., Medtronic Plc, Pfizer Inc. and Teleflex Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/hemostats-and-tissue-sealants-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
o 2.1 Preface
o 2.2 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
o Market ecosystem
o Market characteristics
o Market segmentation analysis
o Value chain analysis
PART 04: MARKET SIZING
o Market definition
o Market sizing 2019
o Market Outlook
o Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
o Market segmentation by product
o Comparison by product
o Hemostats – Market size and forecast 2019-2024
o Tissue sealants and adhesives – Market size and forecast 2019-2024
o Fibrin sealants – Market size and forecast 2019-2024
o Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
o Market drivers
o Market challenges
PART 11: MARKET TRENDS
o Strategic collaborations and acquisitions
o Increasing R&D focus on novel hemostats and tissue sealants
o High growth potential in emerging countries
PART 12: VENDOR LANDSCAPE
o Overview
o Landscape disruption
o Competitive scenario
PART 13: VENDOR ANALYSIS
o Vendors covered
o Vendor classification
o Market positioning of vendors
o Advanced Medical Solutions Group Plc
o B. Braun Melsungen AG
o Baxter International Inc.
o Becton, Dickinson and Co.
o CryoLife Inc.
o Integra LifeSciences Holdings Corp.
o Johnson & Johnson Services Inc.
o Medtronic Plc
o Pfizer Inc.
o Teleflex Inc.
PART 14: APPENDIX
o Research methodology
o List of abbreviations
o Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Hemostats – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Hemostats – Year-over-year growth 2020-2024 (%)
Exhibit 22: Tissue sealants and adhesives – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Tissue sealants and adhesives – Year-over-year growth 2020-2024 (%)
Exhibit 24: Fibrin sealants – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Fibrin sealants – Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America – Year-over-year growth 2020-2024 (%)
Exhibit 32: Increase in the number of various laparoscopic surgical procedures in European countries
Exhibit 33: Number of people aged 65 years and above in EU and countries in 2005 and 2018 (in millions)
Exhibit 34: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 36: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 37: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Advanced Medical Solutions Group Plc – Vendor overview
Exhibit 50: Advanced Medical Solutions Group Plc – Business segments
Exhibit 51: Advanced Medical Solutions Group Plc – Organizational developments
Exhibit 52: Advanced Medical Solutions Group Plc – Geographic focus
Exhibit 53: Advanced Medical Solutions Group Plc – Segment focus
Exhibit 54: Advanced Medical Solutions Group Plc – Key offerings
Exhibit 55: B. Braun Melsungen AG – Vendor overview
Exhibit 56: B. Braun Melsungen AG – Business segments
Exhibit 57: B. Braun Melsungen AG – Organizational developments
Exhibit 58: B. Braun Melsungen AG – Geographic focus
Exhibit 59: B. Braun Melsungen AG – Segment focus
Exhibit 60: B. Braun Melsungen AG – Key offerings
Exhibit 61: Baxter International Inc. – Vendor overview
Exhibit 62: Baxter International Inc. – Business segments
Exhibit 63: Baxter International Inc. – Organizational developments
Exhibit 64: Baxter International Inc. – Geographic focus
Exhibit 65: Baxter International Inc. – Segment focus
Exhibit 66: Baxter International Inc. – Key offerings
Exhibit 67: Becton, Dickinson and Co. – Vendor overview
Exhibit 68: Becton, Dickinson and Co. – Business segments
Exhibit 69: Becton, Dickinson and Co. – Organizational developments
Exhibit 70: Becton, Dickinson and Co. – Geographic focus
Exhibit 71: Becton, Dickinson and Co. – Segment focus
Exhibit 72: Becton, Dickinson and Co. – Key offerings
Exhibit 73: CryoLife Inc. – Vendor overview
Exhibit 74: CryoLife Inc. – Business segments
Exhibit 75: CryoLife Inc. – Organizational developments
Exhibit 76: CryoLife Inc. – Geographic focus
Exhibit 77: CryoLife Inc. – Segment focus
Exhibit 78: CryoLife Inc. – Key offerings
Exhibit 79: Integra LifeSciences Holdings Corp. – Vendor overview
Exhibit 80: Integra LifeSciences Holdings Corp. – Business segments
Exhibit 81: Integra LifeSciences Holdings Corp. – Organizational developments
Exhibit 82: Integra LifeSciences Holdings Corp. – Geographic focus
Exhibit 83: Integra LifeSciences Holdings Corp. – Segment focus
Exhibit 84: Integra LifeSciences Holdings Corp. – Key offerings
Exhibit 85: Johnson & Johnson Services, Inc. – Vendor overview
Exhibit 86: Johnson & Johnson Services, Inc. – Business segments
Exhibit 87: Johnson & Johnson Services, Inc. – Organizational developments
Exhibit 88: Johnson & Johnson Services, Inc. – Geographic focus
Exhibit 89: Johnson & Johnson Services, Inc. – Segment focus
Exhibit 90: Johnson & Johnson Services, Inc. – Key offerings
Exhibit 91: Medtronic Plc – Vendor overview
Exhibit 92: Medtronic Plc – Business segments
Exhibit 93: Medtronic Plc – Organizational developments
Exhibit 94: Medtronic Plc – Geographic focus
Exhibit 95: Medtronic Plc – Segment focus
Exhibit 96: Medtronic Plc – Key offerings
Exhibit 97: Pfizer Inc. – Vendor overview
Exhibit 98: Pfizer Inc. – Business segments
Exhibit 99: Pfizer Inc. – Organizational developments
Exhibit 100: Pfizer Inc. – Geographic focus
Exhibit 101: Pfizer Inc. – Segment focus
Exhibit 102: Pfizer Inc. – Key offerings
Exhibit 103: Teleflex Inc. – Vendor overview
Exhibit 104: Teleflex Inc. – Business segments
Exhibit 105: Teleflex Inc. – Organizational developments
Exhibit 106: Teleflex Inc. – Geographic focus
Exhibit 107: Teleflex Inc. – Segment focus
Exhibit 108: Teleflex Inc. – Key offerings
Exhibit 109: Validation techniques employed for market sizing
Exhibit 110: Definition of market positioning of vendors



【掲載企業】

Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Holdings Corp., Johnson & Johnson Services Inc., Medtronic Plc, Pfizer Inc., Teleflex Inc.

★調査レポート[世界の止血剤&組織シーラント市場2020-2024] (コード:IRTNTR40802 )販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の止血剤&組織シーラント市場2020-2024]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆